Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
reports
Emmaus Life Sciences (EMMA) Stock Price & Analysis
82 Followers
EMMA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.07 - $0.60
Previous Close$0.31
Volume832.00
Average Volume (3M)12.64K
Market Cap
$14.21M
Enterprise Value$47.86M
Total Cash (Recent Filing)$1.77M
Total Debt (Recent Filing)$33.00M
Price to Earnings (P/E)-1.2
Beta0.88
Next Earnings
Aug 14, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding53,637,554
10 Day Avg. Volume6,965
30 Day Avg. Volume12,636
Standard Deviation0.38
R-Squared0.13
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-0.29
Price to Sales (P/S)2.46
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio16.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.18
Enterprise Value/Gross Profit3.03
Enterprise Value/Ebitda-14.99
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Emmaus Life Sciences News
Press ReleasesEmmaus Life Sciences Provides Interim Shipment Data
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EMMA FAQ
What was Emmaus Life Sciences Inc’s price range in the past 12 months?
Emmaus Life Sciences Inc lowest stock price was $0.07 and its highest was $0.60 in the past 12 months.
What is Emmaus Life Sciences Inc’s market cap?
Currently, no data Available
When is Emmaus Life Sciences Inc’s upcoming earnings report date?
Emmaus Life Sciences Inc’s upcoming earnings report date is Aug 14, 2023 which is in 75 days.
How were Emmaus Life Sciences Inc’s earnings last quarter?
Currently, no data Available
Is Emmaus Life Sciences Inc overvalued?
According to Wall Street analysts Emmaus Life Sciences Inc’s price is currently Overvalued.
Does Emmaus Life Sciences Inc pay dividends?
Emmaus Life Sciences Inc does not currently pay dividends.
What is Emmaus Life Sciences Inc’s EPS estimate?
Emmaus Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Emmaus Life Sciences Inc have?
Emmaus Life Sciences Inc has 53,637,554 shares outstanding.
What happened to Emmaus Life Sciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Emmaus Life Sciences Inc?
Currently, no hedge funds are holding shares in EMMA
---
Emmaus Life Sciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.42%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.95%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Emmaus Life Sciences Inc
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company is headquartered in Torrance, CA.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
Context Therapeutics
―
9 Meters Biopharma
―
Cocrystal Pharma
―
Novan
―
Clever Leaves Holdings
―
---